DJ Incyte Corp. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Incyte Corp. $(INCY)$ shed 1.13% to $113.36 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.79% to 7,499.36 and the Dow Jones Industrial Average rising 0.26% to 52,319.20.
The stock's fall snapped a two-day winning streak.
Incyte Corp. closed 1.90% short of its 52-week high of $115.56, which the company achieved on June 26th.
The stock underperformed when compared to some of its competitors Tuesday, as Alnylam Pharmaceuticals Inc. $(ALNY)$ rose 2.56% to $301.03, Bio-Techne Corp. (TECH) fell 0.35% to $70.65, and BioMarin Pharmaceutical Inc. $(BMRN)$ fell 0.78% to $57.22.
Trading volume (1.7 M) remained 40,931 below its 50-day average volume of 1.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 30, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 30, 2026 17:04 ET (21:04 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments